Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Por Pacher, P., Mechoulam, R.
Publicado em 2011

ENDOCANNABINOID SIGNALING IN NEUROTOXICITY AND NEUROPROTECTION

Por Pope, C., Mechoulam, R., Parsons, L.
Publicado em 2009

The anti-nausea effects of CB(1) agonists are mediated by an action at the visceral insular cortex

Por Limebeer, CL, Rock, EM, Mechoulam, R, Parker, LA
Publicado em 2012

Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction.

Por Schuel, H, Goldstein, E, Mechoulam, R, Zimmerman, A M, Zimmerman, S
Publicado em 1994

Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT(1A) receptor activation

Por Magen, I, Avraham, Y, Ackerman, Z, Vorobiev, L, Mechoulam, R, Berry, EM
Publicado em 2010

Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine.

Por Pertwee, R. G., Stevenson, L. A., Elrick, D. B., Mechoulam, R., Corbett, A. D.
Publicado em 1992

Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress

Por Mecha, M, Torrao, A S, Mestre, L, Carrillo-Salinas, F J, Mechoulam, R, Guaza, C
Publicado em 2012

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker.

Por Feigenbaum, J J, Bergmann, F, Richmond, S A, Mechoulam, R, Nadler, V, Kloog, Y, Sokolovsky, M
Publicado em 1989

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice

Por Avraham, Y, Grigoriadis, NC, Poutahidis, T, Vorobiev, L, Magen, I, Ilan, Y, Mechoulam, R, Berry, EM
Publicado em 2011

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Por Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., Feldmann, M.
Publicado em 2000

Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice

Por Avraham, Y, Grigoriadis, NC, Magen, I, Poutahidis, T, Vorobiav, L, Zolotarev, O, Ilan, Y, Mechoulam, R, Berry, EM
Publicado em 2009

Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal ra...

Por Rock, EM, Bolognini, D, Limebeer, CL, Cascio, MG, Anavi-Goffer, S, Fletcher, PJ, Mechoulam, R, Pertwee, RG, Parker, LA
Publicado em 2012

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease

Por Martín-Moreno, Ana María, Reigada, David, Ramírez, Belén G., Mechoulam, R., Innamorato, Nadia, Cuadrado, Antonio, de Ceballos, María L.
Publicado em 2011

HU-308: A specific agonist for CB(2), a peripheral cannabinoid receptor

Por Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., Fride, E.
Publicado em 1999

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma

Por Fisher, T., Golan, H., Schiby, G., PriChen, S., Smoum, R., Moshe, I., Peshes-Yaloz, N., Castiel, A., Waldman, D., Gallily, R., Mechoulam, R., Toren, A.
Publicado no Curr Oncol (2016)

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB(1) and CB(2)

Por Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., Mechoulam, R., Ross, R. A.
Publicado em 2010